Levodopa impurity 1513-IP-1

SL-10856

Levodopa impurity 1513-IP-1, >98%

CAS No. : [2259692-12-9]

IUPAC Name : (1S,3S)-6,7-Dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline-1,3-dicarboxylic acid

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
100MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is an impurity of Levodopa, which is an orally active metabolic precursor of neurotransmitters dopamine. Levodopa can cross the blood-brain barrier and is converted into dopamine in the brain. Levodopa has anti-allodynic effects and the potential for Parkinson's disease.

References : Gigant B. et al.: Nature 435(7041), 519-522, 2005; Lukyanetz E. A. et al.: Epilepsia 43(1), 9-18, 2002; Rigo J. M. et al.: Br. J. Pharmacol., 136(5), 659-672, 2002; Loscher W. et al.: J. Pharmacol Exp Ther., 284(2), 474-479, 1998; Gower A. J. et al.: Epilepsy Res., 22(3), 207-213, 1995.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.